Public Filings

HRTX — HERON THERAPEUTICS, INC. /DE/Today's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.

Congress trades
1
all time
Members · 12m
0
0 buys · 0 sells · by trade date
Latest filing
04-05
2021-04-05
Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
0
every row filed inside 45 days
13F holders
—
issuer resolved · no holder rows
Congress: statutory ranges, filed up to 45 days after the trade · 13F: quarter-end snapshots, filed up to 45 days lateras of 2026-10-23
Congress 1Institutional

Congress · disclosure timeline

By trade date · 24 months · 0 rows ▲ buy, ▼ sell; height = lower bound (log scale). Trade date, not filing date — the filing lag is in the table below.

No dated HRTX rows fall inside the trailing 24 months by trade date.

Members active in HRTX

12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-23).

No member disclosed HRTX in the trailing 12 months.

Congressional disclosures

Newest filed firstAll 1 row ↗
FiledMemberSide · OwnerTraded · LagAmountRange · FlagsSrc
2021-04-05Hinson Arenholz, Ashley —SELL SP03-31 +5d$1K–$15K
PTR ↗

Institutional holders · 13F

Mapped, but not in the published aggregate.

HRTX resolves to HERON THERAPEUTICS, INC. /DE/ (CIK 818033), but this build's aggregate holds no entity-keyed top-holder rows for it. HRTX on SEC EDGAR ↗

Crowding — not available in this build. The ticker resolves to HERON THERAPEUTICS, INC. /DE/ (CIK 818033), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so it cannot be ranked among tracked names.

Congress ↔ notable managers · HRTX

Congress · last 90 days

Buyers
0 — —
Sellers
0 — —

filed 2026-07-25 → 2026-10-23 · statutory ranges

Notable managers

Not available for HRTX: the reviewed 13F name-and-class mapping does not name this ticker yet, so no notable manager's holding of it can be read. how tickers are mapped ↗

No moves on either side in the window.

Congress vs filers

12 months
Congress net (rows)no rows
Congress net ($ bound)$0
Filersnot computedThe ticker resolves to HERON THERAPEUTICS, INC. /DE/ (CIK 818033), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so the filer side cannot be computed. Convergence and divergence are stated only when both sides are computed.